Abstract
Approximately 15% of cerebral strokes in adults are due to bleeding into the brain (intracerebral hemorrhage, ICH). This can be related to hypertension, vascular anomalies, or coagulopathy. Prognosis following ICH is worse than that following ischemic stroke. In addition, head trauma and premature birth are associated with ICH. Inflammation occurs after ICH and might be an important part of the pathogenesis of brain damage. The goal of this review is to bring together recent diverse data concerning inflammation after ICH. There has been little investigation of the role of inflammation following ICH despite the fact that inflammation is more severe than in ischemic stroke. Inflammation in the brain follows a temporal sequence similar to that in other organs. Some cytokines and inflammatory cells may possess dual roles both deleterious and beneficial to brain after ICH. At present, experimental data only weakly support pursuit of pharmacologic anti-inflammatory strategies following ICH.
Keywords: inflammation, cytokines, adhesion molecules, leukocytes, ich, brain trauma, animal models, anti-inflammation
Current Neuropharmacology
Title: Brain Inflammation Following Intracerebral Hemorrhage
Volume: 1 Issue: 4
Author(s): Mengzhou Xue, Janani Balasubramaniam and Marc R. Del Bigio
Affiliation:
Keywords: inflammation, cytokines, adhesion molecules, leukocytes, ich, brain trauma, animal models, anti-inflammation
Abstract: Approximately 15% of cerebral strokes in adults are due to bleeding into the brain (intracerebral hemorrhage, ICH). This can be related to hypertension, vascular anomalies, or coagulopathy. Prognosis following ICH is worse than that following ischemic stroke. In addition, head trauma and premature birth are associated with ICH. Inflammation occurs after ICH and might be an important part of the pathogenesis of brain damage. The goal of this review is to bring together recent diverse data concerning inflammation after ICH. There has been little investigation of the role of inflammation following ICH despite the fact that inflammation is more severe than in ischemic stroke. Inflammation in the brain follows a temporal sequence similar to that in other organs. Some cytokines and inflammatory cells may possess dual roles both deleterious and beneficial to brain after ICH. At present, experimental data only weakly support pursuit of pharmacologic anti-inflammatory strategies following ICH.
Export Options
About this article
Cite this article as:
Xue Mengzhou, Balasubramaniam Janani and Bigio R. Del Marc, Brain Inflammation Following Intracerebral Hemorrhage, Current Neuropharmacology 2003; 1 (4) . https://dx.doi.org/10.2174/1570159033477008
DOI https://dx.doi.org/10.2174/1570159033477008 |
Print ISSN 1570-159X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6190 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
- Forthcoming Thematic Issues
Related Articles
-
Therapeutic Application of Endothelial Progenitor Cells for Treatment of Cardiovascular Diseases
Current Stem Cell Research & Therapy Individual Triptan Selection in Migraine Attack Therapy
Recent Patents on CNS Drug Discovery (Discontinued) The Problem of Atrial Fibrillation in Patients with Chronic Kidney Disease
Current Vascular Pharmacology Cardiovascular Diseases and the Nitric Oxide Pathway
Current Vascular Pharmacology Non-pharmacological Modulation of the Autonomic Nervous System for Heart Failure Treatment: Where do We Stand?
Current Vascular Pharmacology Global Cerebral Ischemia: Synaptic and Cognitive Dysfunction
Current Drug Targets Cerebral Amyloid Angiopathy-related Intracerebral Hemorrhage Score For Predicting Outcome
Current Neurovascular Research Hemolytic Uremic Syndrome in Children
Current Pediatric Reviews Protective and Therapeutic Effects of Ghrelin in the Gut
Current Medicinal Chemistry Reversing Agents for ATP-Binding Cassette (ABC) Transporters: Application in Modulating Multidrug Resistance (MDR)
Current Medicinal Chemistry - Anti-Cancer Agents Expression, Purification, and Characterization of an Enzymatically Active Truncated Human Rho-Kinase I (ROCK I) Domain Expressed in Sf-9 Insect Cells
Protein & Peptide Letters Glaucoma Pathogenesis and Neurotrophins: Focus on the Molecular and Genetic Basis for Therapeutic Prospects
Current Neuropharmacology Patent Selections
Recent Patents on DNA & Gene Sequences Chronic Methylphenidate-Effects Over Circadian Cycle of Young and Adult Rats Submitted to Open-Field and Object Recognition Tests
Current Neurovascular Research Effect of Aglycon and Glycoside Flavonoid-Enriched Extracts Obtained from Buxus sempervirens L. on Glucose and Lipid Metabolism in Diabetic Rats
Cardiovascular & Hematological Agents in Medicinal Chemistry Cardiac Adrenomedullin: Its Role in Cardiac Hypertrophy and Heart Failure
Current Medicinal Chemistry - Cardiovascular & Hematological Agents Diverse combination therapies of Chinese Medicine in treating Hypertension
Current Vascular Pharmacology Etanercept Improves Cognitive Performance and Increases eNOS and BDNF Expression During Experimental Vascular Dementia in Streptozotocin- induced Diabetes
Current Neurovascular Research Proteinase-Activated Receptor-2: Physiological and Pathophysiological Roles
Current Medicinal Chemistry - Cardiovascular & Hematological Agents Recent Advances in the Discovery and Development of Marine Natural Products with Cardiovascular Pharmacological Effects
Mini-Reviews in Medicinal Chemistry